Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Effects of supplemental vitamin D and calcium on biomarkers of inflammation in colorectal adenoma patients: a randomized, controlled clinical trial.

Hopkins MH, Owen J, Ahearn T, Fedirko V, Flanders WD, Jones DP, Bostick RM.

Cancer Prev Res (Phila). 2011 Oct;4(10):1645-54. doi: 10.1158/1940-6207.CAPR-11-0105.

2.

The NF-κB/AKT-dependent Induction of Wnt Signaling in Colon Cancer Cells by Macrophages and IL-1β.

Kaler P, Godasi BN, Augenlicht L, Klampfer L.

Cancer Microenviron. 2009 Sep 25;2(1):69-80. doi: 10.1007/s12307-009-0030-y.

3.

Cancer statistics, 2009.

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ.

CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49. doi: 10.3322/caac.20006.

4.

Effects of vitamin D and calcium supplementation on markers of apoptosis in normal colon mucosa: a randomized, double-blind, placebo-controlled clinical trial.

Fedirko V, Bostick RM, Flanders WD, Long Q, Shaukat A, Rutherford RE, Daniel CR, Cohen V, Dash C.

Cancer Prev Res (Phila). 2009 Mar;2(3):213-23. doi: 10.1158/1940-6207.CAPR-08-0157.

5.

Smoking and colorectal cancer: a meta-analysis.

Botteri E, Iodice S, Bagnardi V, Raimondi S, Lowenfels AB, Maisonneuve P.

JAMA. 2008 Dec 17;300(23):2765-78. doi: 10.1001/jama.2008.839.

PMID:
19088354
6.

Vitamin D and prevention of colorectal adenoma: a meta-analysis.

Wei MY, Garland CF, Gorham ED, Mohr SB, Giovannucci E.

Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):2958-69. doi: 10.1158/1055-9965.EPI-08-0402.

7.

Serum interleukin 6 (IL-6) and C-reactive protein (CRP) levels in colorectal adenoma and cancer patients.

Groblewska M, Mroczko B, Wereszczyńska-Siemiatkowska U, Kedra B, Lukaszewicz M, Baniukiewicz A, Szmitkowski M.

Clin Chem Lab Med. 2008;46(10):1423-8. doi: 10.1515/CCLM.2008.278.

PMID:
18844497
8.

Systematic review of the association between circulating interleukin-6 (IL-6) and cancer.

Heikkilä K, Ebrahim S, Lawlor DA.

Eur J Cancer. 2008 May;44(7):937-45. doi: 10.1016/j.ejca.2008.02.047. Review.

PMID:
18387296
9.

Circulating levels of inflammatory cytokines and risk of colorectal adenomas.

Kim S, Keku TO, Martin C, Galanko J, Woosley JT, Schroeder JC, Satia JA, Halabi S, Sandler RS.

Cancer Res. 2008 Jan 1;68(1):323-8. doi: 10.1158/0008-5472.CAN-07-2924.

10.

The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas.

Giovannucci E, Michaud D.

Gastroenterology. 2007 May;132(6):2208-25. Review.

PMID:
17498513
11.
12.

Inflammation-related gene polymorphisms and colorectal adenoma.

Gunter MJ, Canzian F, Landi S, Chanock SJ, Sinha R, Rothman N.

Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1126-31.

13.

Moderate alcohol consumption and lower levels of inflammatory markers in US men and women.

Pai JK, Hankinson SE, Thadhani R, Rifai N, Pischon T, Rimm EB.

Atherosclerosis. 2006 May;186(1):113-20.

PMID:
16055129
14.

Clinical significance of serum cytokine measurements in untreated colorectal cancer patients: soluble tumor necrosis factor receptor type I--an independent prognostic factor.

Kaminska J, Nowacki MP, Kowalska M, Rysinska A, Chwalinski M, Fuksiewicz M, Michalski W, Chechlinska M.

Tumour Biol. 2005 Jul-Aug;26(4):186-94.

PMID:
16006772
15.

Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications.

Nikiteas NI, Tzanakis N, Gazouli M, Rallis G, Daniilidis K, Theodoropoulos G, Kostakis A, Peros G.

World J Gastroenterol. 2005 Mar 21;11(11):1639-43.

16.

C-reactive Protein.

Black S, Kushner I, Samols D.

J Biol Chem. 2004 Nov 19;279(47):48487-90. Review.

17.

Tumour necrosis factor alpha: a potential target for the therapy of solid tumours.

Szlosarek PW, Balkwill FR.

Lancet Oncol. 2003 Sep;4(9):565-73. Review.

PMID:
12965278
18.

Serum interleukin-6 levels reflect the disease status of colorectal cancer.

Chung YC, Chang YF.

J Surg Oncol. 2003 Aug;83(4):222-6.

PMID:
12884234
19.

Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer.

Landi S, Moreno V, Gioia-Patricola L, Guino E, Navarro M, de Oca J, Capella G, Canzian F; Bellvitge Colorectal Cancer Study Group..

Cancer Res. 2003 Jul 1;63(13):3560-6.

20.

Is obesity an inflammatory condition?

Das UN.

Nutrition. 2001 Nov-Dec;17(11-12):953-66. Review.

PMID:
11744348
Items per page

Supplemental Content

Support Center